Second month sputum smear as a predictor of tuberculosis treatment outcomes in Brazil

BMC Res Notes. 2018 Jun 28;11(1):414. doi: 10.1186/s13104-018-3522-3.

Abstract

Objective: The value of sputum smear microscopy (SSM) after 2 months of treatment in the management of pulmonary tuberculosis is controversial. We analysed second month-SSM conversion as a predictor of treatment success in Brazil.

Results: Overall successful outcome rate was 89.4%. The predictive value of second month-SSM conversion for successful outcomes was 85.2% 72,479/85,118), while the predictive value of non-conversion for unfavourable outcomes was 26.9% (2712/10,071). Unfavourable treatment outcomes were twice more likely among patients who did not convert (adjusted OR = 2.06; 1.97-2.16).

Keywords: Acid-fast bacilli; Predictive value; Pulmonary tuberculosis; Sputum smear microscopy; Treatment outcomes.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antitubercular Agents / therapeutic use*
  • Brazil
  • Female
  • Humans
  • Infant, Newborn
  • Male
  • Middle Aged
  • Mycobacterium tuberculosis
  • Sputum / microbiology*
  • Treatment Outcome
  • Tuberculosis, Pulmonary / drug therapy*
  • Young Adult

Substances

  • Antitubercular Agents